We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
GUK-based drug major GlaxoSmithKline's vaccines unit,
GSK Biologicals, has outlined plans to develop its Indian operations into a
leading centre for vaccines discovery.
UK-based drug major GlaxoSmithKline (GSK) has reportedly returned much of its
co-promotion rights for erectile dysfunction treatment Levitra (vardenafil)
to Germany's Bayer Healthcare.
Swiss drugmaker has signed an exclusive license and distribution agreement with
Indonesian drug producer Kalbe Farma for its Aloxi (Palonosetron hydrochloride)
product.
The Chinese Food and Drug Administration has reportedly
issued its final approval for a combined hepatitis A and B vaccine produced
by local company Sinovac.
Groups representing Nigerian HIV/AIDS patients have alleged
that the country's Federal Health Ministry may have inappropriately approved
medicines removed from the World Health Organisation's list of HIV/AIDS treatments.
Local pharmaceutical groups have criticised recently introduced Lithuanian regulations,
which allegedly prevent new companies from obtaining import licenses, as well
as making wholesale permits prohibitively expensive.